Annual report [Section 13 and 15(d), not S-K Item 405]

ORGANIZATION AND DESCRIPTION OF BUSINESS (Detail Narrative)

v3.25.4
ORGANIZATION AND DESCRIPTION OF BUSINESS (Detail Narrative) - USD ($)
1 Months Ended 12 Months Ended
Sep. 05, 2025
Sep. 04, 2025
Jun. 12, 2025
May 01, 2025
Oct. 28, 2025
Sep. 30, 2025
Jul. 18, 2025
Dec. 31, 2025
Dec. 31, 2024
Stock issued during period, value               $ 6,151,000 $ 112,000
Interest rate         12.00%        
Common stock, par value         $ 0.001     $ 0.001 $ 0.001
Net loss               $ (12,879,000) $ (9,826,000)
Common stock, shares authorized               500,000,000 500,000,000
Conversion price               $ 3.40  
Common Stock, Shares Outstanding               2,018,746 567,582
Preferred stock, shares authorized               69,444 69,444
Sale of stock               $ 75,000,000  
Proceeds from sale of stock               6,151,000 $ 112,000
Gross proceeds from issuance of warrants               1,425  
Warrant share transaction costs               346,000  
Proceeds from issuance of warrants               1,079,000  
Aggregate value shelf registration statement               75,000,000  
Cash and cash equivalents               600,000  
Public float less than               $ 75,000,000  
Unsecured Convertible Notes [Member]                  
Interest rate       12.00%          
Gross proceeds       $ 900,000          
Conversion price       $ 6.24          
Acquisition of notes by related party       $ 350,000          
Subscription agreement, description         pursuant to which it issued and sold to certain investors (the “Investors”), and the Investors purchased (by converting all or a portion of the unconverted “Voluntary Conversion” portion of unpaid principal balance and accrued interest due to such Investors upon the maturity of the convertible promissory notes issued to the Investors on May 1, 2025): (i) convertible notes (the “Notes”) to the Investors in an aggregate principal amount of $692, of which $195 was to related parties; and (ii) warrants (the “Warrants”) to purchase an aggregate of 438,182 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), at an exercise price of $3.40 per share (collectively, the “Offering”). The Notes have a maturity of 180 days and bear interest at 12.0%        
Private Placement [Member]                  
Stock issued during period, shares               136,843  
Exercise price               $ 5.82  
5.82 Warrant [Member]                  
Stock issued during period, shares               460,046  
Exercise price               $ 5.82  
10.00Warrant [Member]                  
Stock issued during period, shares               230,023  
Exercise price               $ 10.00  
Reserven Stock Split Member                  
Common stock, par value     $ 0.001            
Common stock, shares authorized     50,000,000         8,333,333  
Common Stock, Shares Outstanding     3,280,000         546,667  
Preferred stock, shares authorized     416,667,000         69,444,000  
Reverse stock split, description     (1-for-6)            
Pre-funded Warrants [Member]                  
Stock issued during period, shares           13,335   93,180  
Common stock, par value           $ 0.001   $ 0.001  
Exercise price           $ 4.399   $ 5.819  
Certificate of Change [Member]                  
Common stock, par value     $ 0.001            
Securities purchase agreement [Member]                  
Equity offering description               purchase and sale of securities at a price of $10.45 per unit, consisting of: (a) 906,687 shares of common stock (or pre-funded warrants in lieu thereof); (b) three-year warrants to purchase 906,687 shares of common stock at an exercise price of $10.20 per share; and (c) three-year warrants to purchase 906,687 shares of common stock at an exercise price of $50.00 per share  
Proceeds from sale of stock               $ 9,475,000  
Underwriting Agreement [Member]                  
Stock issued during period, shares 57,914         441,210      
Stock issued during period, value $ 237                
Additional shares granted 102,272         68,181      
Common stock, par value   $ 0.001       $ 0.001      
Exercise price   $ 4.40       $ 4.40      
Equity offering description   (i) 640,924 shares of common stock at a price to the public of $4.40 per share, and (ii) pre-funded warrants to purchase up to 40,894 shares of common stock at an exercise price of $0.001 per share, at a price to the public of $4.399 per pre-funded warrant       (i) 441,210 shares (the “Shares”) of common stock, par value $0.001 per share, of the Company at a price to the public of $4.40 per share (the “Share Purchase Price”), and (ii) pre-funded warrants to purchase up to 13,335 shares of common stock at an exercise price of $0.001 per share at a price to the public of $4.399 per pre-funded warrant      
Proceeds from sale of stock   $ 2,690,000       $ 1,760,000      
Gross proceed   3,000,000       2,000,000      
Offering expenses   $ 310       $ 240      
Bottom [Member] | Reserven Stock Split Member                  
Common stock, shares authorized               8,333,333  
Top [Member] | Reserven Stock Split Member                  
Common stock, shares authorized               500,000,000  
Sales Agreement [Member]                  
Stock issued during period, shares               50,858  
Proceeds from sale of stock               $ 442  
Authorized capacity of ATM program             $ 6,500,000